What did the company owe Zimbler for? Was it a debt, severance package, or something else that was incurred during the time of the predecessor? If he is a former Director shouldn't his annual payments be coming from Robustomed? Aside from his annual payment, there is no mention of his role in the current Enzolytics (post Enzolytics and BioClonetics merger). If the CCC team do gain control of ENZC will Charles continue this annual payment to James?
Note 6. Related Party Transactions As of March 31, 2024 and December 31, 2023, the Company owed to Directors, officers, and stockholders of the Company $353,101 and $343,101, respectively. The amounts are unsecured, noninterest bearing, and have no terms for repayment. The individual amounts owed to Directors, officers and stockholders are presented as follows: As of March 31, 2024 December 31, 2023 James W. Zimbler 142,646 142,646 Harry Zhabilov 200,455 200,455 Charles Cotropia 10,000 For a total of $353,101 $343,101
James W. Zimbler, a former Director and stockholder of the Company